MAPT and Alzheimer disease: The temporal evolution of keyword prominence, particularly the marked increase in “tau” (2018–2024, Figure 5B), signifies a pivotal paradigm shift in AD research—from amyloid-beta (Aβ)-centric frameworks toward tauopathy-driven mechanistic exploration.